Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
Main Authors: | Beatrice Copps, BSc, Jean-Philip Lacroix, MD, Denis Sasseville, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512617300590 |
Similar Items
-
Symmetrical drug-related intertriginous and flexural exanthema
(baboon syndrome) caused by cotrimoxazole
by: Neelam Bhatt, et al.
Published: (2021-05-01) -
Co-occurrence of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) and pigmented Fixed drug eruption (FDE) in a single patient due to Doxycycline: A case report
by: Kananbala Sahu, et al.
Published: (2020-01-01) -
Systemic Drug Related Intertriginous and Flexural Exanthema (SDRIFE) or Intertriginous Drug Eruption: a matter of semantics
by: Dhaarna Wadhwa, et al.
Published: (2019-01-01) -
Hydroxyzine-induced Baboon syndrome: A rare case report
by: B S Chandrashekar, et al.
Published: (2020-01-01) -
Intertriginous drug eruptions
by: Mahajan Vikram, et al.
Published: (2005-01-01)